Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.verified

HEPA

Price:

$1.03

Market Cap:

$5.64M

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The co...[Read more]

Industry

Biotechnology

IPO Date

2014-02-10

Stock Exchange

NASDAQ

Ticker

HEPA

The Enterprise Value as of June 2024 (TTM) for Hepion Pharmaceuticals, Inc. (HEPA) is -7292910.00

According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -7292910.00. This represents a change of -423.43% compared to the average of 2.25M of the last 4 quarters.

Hepion Pharmaceuticals, Inc. (HEPA) Historical Enterprise Value (quarterly & annually)

How has HEPA Enterprise Value performed in the past?

The mean historical Enterprise Value of Hepion Pharmaceuticals, Inc. over the last ten years is 10.03M. The current -7292910.00 Enterprise Value has changed -7369.72% with respect to the historical average. Over the past ten years (40 quarters), HEPA's Enterprise Value was at its highest in in the March 2017 quarter at 105.91M. The Enterprise Value was at its lowest in in the December 2021 quarter at -91031975.00.

Quarterly (TTM)
Annual

Average

10.03M

Median

262.77K

Minimum

-28266642.00

Maximum

105.93M

Hepion Pharmaceuticals, Inc. (HEPA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 767.95%

Maximum Annual Enterprise Value = 105.93M

Minimum Annual Increase = -196.73%

Minimum Annual Enterprise Value = -28266642.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-1711435.60-93.95%
2022-28266642.00159.34%
2021-10899642.20-41.96%
2020-18780246.20767.95%
2019-2163758.60-196.73%
20182.24M-89.26%
201720.82M0.36%
201620.75M-80.41%
2015105.93M753.96%
201412.40M-95.52%

Hepion Pharmaceuticals, Inc. (HEPA) Average Enterprise Value

How has HEPA Enterprise Value performed in the past?

The current Enterprise Value of Hepion Pharmaceuticals, Inc. (HEPA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-13625906.60

5-year avg

-12364344.92

10-year avg

10.03M

Hepion Pharmaceuticals, Inc. (HEPA) Enterprise Value vs. Peers

How is HEPA’s Enterprise Value compared to its peers?

Hepion Pharmaceuticals, Inc.’s Enterprise Value is less than Enveric Biosciences, Inc. (-928861.00), less than CohBar, Inc. (-3982786.00), less than Elevation Oncology, Inc. (102.73M), less than Ocean Biomedical, Inc. (65.07M), greater than AVROBIO, Inc. (-24995198.00), less than Zura Bio Limited (147.72M), less than eFFECTOR Therapeutics, Inc. (9.47M),

CompanyEnterprise ValueMarket cap
-928861.00$5.43M
-3982786.00$2.21M
102.73M$162.55M
65.07M$54.05M
-24995198.00$65.54M
147.72M$237.54M
9.47M$5.83M

Build a custom stock screener for Hepion Pharmaceuticals, Inc. (HEPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hepion Pharmaceuticals, Inc. (HEPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hepion Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?

What is the 3-year average Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?

What is the 5-year average Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?

How does the current Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA) compare to its historical average?